Håvard Midgard
Biographic Data
| ID | 7446523 |
|---|---|
| NAME | Håvard Midgard |
| GIVEN NAMES | Håvard |
| FAMILY NAME | Midgard |
| SIGNATURE | MIDGARD H |
| AFFILIATIONS | Oslo University Hospital |
| ORCID | 0000-0001-5043-5107 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Changes in Risk Behaviour Among People With Recent Injecting Drug Use in Oslo 2002–2024
Towards elimination of hepatitis C in Oslo
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway
Although HCV treatment uptake among PWID increased, strategies to improve treatment among women and individuals not engaged in OAT should be addressed
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
No prominent works on this page.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway
Although HCV treatment uptake among PWID increased, strategies to improve treatment among women and individuals not engaged in OAT should be addressed
Towards elimination of hepatitis C in Oslo
Changes in Risk Behaviour Among People With Recent Injecting Drug Use in Oslo 2002–2024
Hepatitis C virus research (7 works) · Hepatitis C (6 works) · Medicine (6 works) · Internal Medicine (5 works) · Hepatitis B Virus Studies (4 works) · HIV, Drug Use, Sexual Risk (4 works) · Drug (3 works) · Hepatitis C virus (3 works) · Immunology (3 works) · Liver Disease Diagnosis and Treatment (3 works)